Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Mooswiesen 2, Ravensburg, Baden-Wuerttemberg 88214, Germany (DEU)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3005987757 · DUNS 312670654
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2023-07-21
- VAIDrug Quality Assurance2020-07-20
- NAIDrug Quality Assurance2018-06-12
- VAIBlood and Blood Products2017-11-02
- NAIDrug Quality Assurance2016-07-26
- VAIDrug Quality Assurance2014-12-05
- NAIDrug Quality Assurance2013-10-28
- NAIDrug Quality Assurance2012-07-20
- VAIDrug Quality Assurance2010-04-01
Drugs this plant is listed as making
7 distinct drugs across 13 products name this site in their FDA label.
- abaloparatideRadius Health, Inc.
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtlBioverativ Therapeutics Inc.
- DaratumumabJanssen Biotech, Inc.
- Efgartigimod Alfaargenx US
- fitusiranGenzyme Corporation
- nemolizumab-iltoGalderma Laboratories, L.P.
- nipocalimab-aahuJanssen Biotech, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.